Atlas Trials

Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?

Clinical trial NCT01699230 · UNKNOWN

Trial details

NCT number
NCT01699230
Sponsor
University Hospital, Clermont-Ferrand
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Coronary Atherosclerosis
Start date
2011-03-01
Primary completion
2013-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.